register

Digital & Innovation

Report highlights digital health industry engagement with Australian regulatory framework

Health Industry Hub | March 3, 2021 |

Digital & Innovation: Digital health technologies (DHTs) have the potential to disrupt both the medical technology, biotechnology and pharmaceutical sector and the broader delivery of healthcare, creating challenges for the effective and timely regulation of new therapeutic goods.

MTPConnect’s new report Adaptive Regulation for Digital Health: Enhancing Australia’s Regulation System examines how digital health industry stakeholders are engaging with the Australian therapeutic goods regulatory framework, using case studies to highlight the rapid and diverse development pathways for digital medical devices in Australia.

Focusing on DHTs regulated as medical devices – including software as a medical device (SaMD) and physical medical devices with associated software – the research has sought to cover the following:

International Women's Day 2021 - Health Industry Hub
Interview links will be provided via email next week.
  1.  Ascertain the current state of knowledge regarding regulatory pathways and regulation compliance for DHTs;
  2. Identify key challenges in digital health regulation within the current regulatory framework;
  3. Identify potential alignments and misalignments between current regulatory requirements and new product development processes;
  4. Clarify how current regulatory policies and frameworks could accommodate an adaptive approach to digital health regulation; and
  5. Identify areas where greater education and awareness are needed within industry.

The research presented in this report was funded by MTPConnect and conducted by researchers at The University of Queensland’s (UQ) Australian Institute for Business and Economics (AIBE) with support from Steering Committee representatives from the Therapeutic Goods Administration, CSIRO, ANDHealth, University of Queensland and Allens.

Australia has an opportunity to take the global lead in ensuring timely consumer access to cutting-edge medical technologies. This report is critical reading for start-ups and innovators developing digital health technologies.

Click here to view the report.


News & Trends - MedTech & Diagnostics

Health insurers clash with government decision on GUIs, prompting threat of premium hikes

Health insurers clash with government on GUIs decision, prompting threat of premium hikes

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A warning of potential increases in health insurance premiums for 15 million Australians has been issued […]

More


News & Trends - MedTech & Diagnostics

Catheter ablation underused in atrial fibrillation despite proven efficacy

Catheter ablation underused in atrial fibrillation despite proven efficacy

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A new study highlights that nearly half of all patients hospitalised for atrial fibrillation (AF) in […]

More


News & Trends - Biotechnology

How prepared are we for the next pandemic?

How prepared are we for the next pandemic?

Health Industry Hub | May 2, 2024 |

Biotech News: The Melbourne biotechnology community came together for a symposium hosted by BioMelbourne and mRNA Victoria, featuring specialists in […]

More


News & Trends - Pharmaceuticals

AbbVie's JAK inhibitor triumphs: Head-to-Head trial reveals superior outcomes in atopic dermatitis

AbbVie’s JAK inhibitor triumphs: Head-to-Head trial reveals superior outcomes in atopic dermatitis

Health Industry Hub | May 2, 2024 |

Pharma News: In a head-to-head trial, AbbVie’s JAK inhibitor Rinvoq (upadacitinib) showed superior efficacy over Regeneron and Sanofi’s Dupixent (dupilumab) […]

More


This content is copyright protected. Please subscribe to gain access.